{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:31:13Z","timestamp":1791099073855,"version":"4.1.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2191,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Large liver cell change (LLCC) refers to microscopic lesions often found in various chronic liver diseases; however, its nature is still controversial. Thirty-four formalin-fixed and 19 fresh frozen hepatitis B virus (HBV)-related cirrhosis samples were examined for the presence of LLCC, small liver cell change (SLCC), and hepatocellular carcinoma (HCC). The cell cycle checkpoint status (p21, p27, p16, Tp53), cell dynamics (proliferating cell nuclear antigen, Ki-67, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling, M30), DNA damage (\u03b3-H2AX [H2A histone family, member X]), telomere lengths, chromosomal instability (micronuclei index), and senescence-associated \u03b2-galactosidase (SA-\u03b2-Gal) activity were evaluated using an <jats:italic toggle=\"yes\">in situ<\/jats:italic> approach and compared to those in normal liver (n = 5) and liver with chronic cholestasis (34 cases of hepatolithiasis and three cases of primary biliary cirrhosis). In HBV-related cirrhosis, the p21, p27, and p16 cell cycle checkpoint markers were activated in normal-looking cirrhotic hepatocytes (NLCH), but diminished gradually from LLCC, SLCC, to HCC, with an increase in Tp53 expression. There was a general decrease in telomere length from NLCH, LLCC, SLCC, to HCC. Micronuclei, \u03b3-H2AX foci, and net cellular gain were significantly increased from normal hepatocytes, NLCH, LLCC, SLCC, to HCC. The SA-\u03b2-Gal activity was weaker in LLCC compared to NLCH and absent in SLCC and HCC. In contrast, cholestatic LLCC showed retained expression of cell cycle checkpoint markers and decreased net cellular gain compared to adjacent normal-looking hepatocytes. HBV-related LLCC showed significantly higher Tp53 labeling index, \u03b3-H2AX labeling index, and micronuclei index; shorter telomere length; decreased SA-\u03b2-Gal activity; and increased net cellular gain compared to cholestatic LLCC. <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic> The nature of LLCC is rather heterogeneous depending on the biological setting. The characteristics of HBV-related LLCC are more consistent with dysplastic rather than merely reactive hepatocytes, whereas cholestatic LLCC more likely represents reactive change with more stringent cell cycle checkpoint control. (Hepatology 2009.)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.23072","type":"journal-article","created":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T14:22:31Z","timestamp":1242051751000},"page":"752-762","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":67,"title":["Large liver cell change in hepatitis B virus\u2013related liver cirrhosis #"],"prefix":"10.1097","volume":"50","author":[{"given":"Haeryoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Kyeong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Roncalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Mi","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Nyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20241201","first-page":"115","article-title":"Pathological assessment of liver cell dysplasia and benign liver tumors: differentiation from malignant tumors.","volume":"7","author":"Crawford","year":"1990","journal-title":"Semin Diagn Pathol"},{"key":"R2-14-20241201","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2006.08.002","article-title":"Large liver cell dysplasia: a controversial entity.","volume":"45","author":"Park","year":"2006","journal-title":"J Hepatol"},{"key":"R3-14-20241201","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/1097-0142(19830615)51:12<2197::AID-CNCR2820511208>3.0.CO;2-5","article-title":"Morphologic studies of the liver cell dysplasia.","volume":"51","author":"Watanabe","year":"1983","journal-title":"Cancer"},{"key":"R4-14-20241201","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jcp.26.3.217","article-title":"Liver cell dysplasia: a premalignant condition.","volume":"26","author":"Anthony","year":"1973","journal-title":"J Clin Pathol"},{"key":"R5-14-20241201","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1478-3231.2005.01016.x","article-title":"Preneoplastic lesions in human hepatocarcinogenesis.","volume":"25","author":"Libbrecht","year":"2005","journal-title":"Liver Int"},{"key":"R6-14-20241201","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/mp.54.4.270","article-title":"Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridization.","volume":"54","author":"Marchio","year":"2001","journal-title":"Mol Pathol"},{"key":"R7-14-20241201","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ijc.2910440203","article-title":"Abnormal DNA content in liver cell dysplasia: a flow cytometric study.","volume":"44","author":"Roncalli","year":"1989","journal-title":"Int J Cancer"},{"key":"R8-14-20241201","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0046-8177(92)90126-N","article-title":"Liver cell dysplasia: a DNA aneuploid lesion with distinct morphologic features.","volume":"23","author":"Thomas","year":"1992","journal-title":"Hum Pathol"},{"key":"R9-14-20241201","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/hep.1840170416","article-title":"DNA image cytometric analysis of macroregenerative nodules (adenomatous hyperplasia) of the liver: evidence in support of their preneoplastic nature.","volume":"17","author":"Orsatti","year":"1993","journal-title":"HEPATOLOGY"},{"key":"R10-14-20241201","first-page":"677","article-title":"Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma.","volume":"7","author":"Rubin","year":"1994","journal-title":"Mod Pathol"},{"key":"R11-14-20241201","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1155\/2004\/638136","article-title":"DNA ploidy and liver cell dysplasia in liver biopsies from patients with liver cirrhosis.","volume":"18","author":"ElSayed","year":"2004","journal-title":"Can J Gastroenterol"},{"key":"R12-14-20241201","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH690>3.0.CO;2-#","article-title":"Molecular cytogenetic evaluation of virusassociated and nonviral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.","volume":"192","author":"Zondervan","year":"2000","journal-title":"J Pathol"},{"key":"R13-14-20241201","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0168-8278(97)80177-8","article-title":"Interphase cytogenetic analysis reveals numerical chromosome aberrations in large liver cell dysplasia.","volume":"27","author":"Terris","year":"1997","journal-title":"J Hepatol"},{"key":"R14-14-20241201","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000082090","article-title":"Large liver cell dysplasia in hepatitis B virus X transgenic mouse liver and human chronic hepatitis B virusinfected liver.","volume":"48","author":"Koo","year":"2005","journal-title":"Intervirology"},{"key":"R15-14-20241201","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/hep.510280409","article-title":"Clonal analysis of macronodules in cirrhosis.","volume":"28","author":"Paradis","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R16-14-20241201","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/MCG.0b013e318038159d","article-title":"Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B.","volume":"42","author":"Koo","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R17-14-20241201","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1365-2559.2001.01172.x","article-title":"Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with noncirrhotic and cirrhotic chronic viral hepatitis.","volume":"39","author":"Libbrecht","year":"2001","journal-title":"Histopathology"},{"key":"R18-14-20241201","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/hep.510260607","article-title":"Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched casecontrol study, pathological analysis, and pathogenetic hypothesis.","volume":"26","author":"Lee","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R19-14-20241201","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1101\/gad.1214504","article-title":"Functional links between telomeres and proteins of the DNAdamage response.","volume":"18","author":"di Fagagna","year":"2004","journal-title":"Genes Dev"},{"key":"R20-14-20241201","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/labinvest.3700673","article-title":"Role of telomeres and telomerase in genomic instability, senescence and cancer.","volume":"87","author":"Deng","year":"2007","journal-title":"Lab Invest"},{"key":"R21-14-20241201","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2004.09.002","article-title":"Connecting mitotic instability and chromosome aberrations in cancer-can telomeres bridge the gap?","volume":"15","author":"Gisselsson","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"R22-14-20241201","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1073\/pnas.0510877103","article-title":"Reprogramming of replicative senescence in hepatocellular carcinomaderived cells.","volume":"103","author":"Ozturk","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-14-20241201","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/sj.onc.1207518","article-title":"Hallmarks of senescence in carcinogenesis and cancer therapy.","volume":"23","author":"Shay","year":"2004","journal-title":"Oncogene"},{"key":"R24-14-20241201","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.20271","article-title":"Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma.","volume":"40","author":"Plentz","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R25-14-20241201","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.20847","article-title":"Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.","volume":"42","author":"Plentz","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R26-14-20241201","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0027-5107(00)00065-8","article-title":"The in vitro micronucleus technique.","volume":"455","author":"Fenech","year":"2000","journal-title":"Mutation Res"},{"key":"R27-14-20241201","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cancergencyto.2003.08.001","article-title":"Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.","volume":"150","author":"de Almeida","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"R28-14-20241201","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/436636a","article-title":"Crime and punishment.","volume":"436","author":"Sharpless","year":"2005","journal-title":"Nature"},{"key":"R29-14-20241201","first-page":"472","article-title":"The power and the promise of oncogeneinduced senescence markers.","volume":"6","author":"Collado","year":"2006","journal-title":"Nature Rev"},{"key":"R30-14-20241201","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/436642a","article-title":"Tumour biology: senescence in premalignant tumours.","volume":"436","author":"Collado","year":"2005","journal-title":"Nature"},{"key":"R32-14-20241201","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1038\/sj.onc.1210578","article-title":"Genetic cooperation between p21CIP1 and INK4 inhibitors in cellular senescence and tumor suppression.","volume":"26","author":"Quereda","year":"2007","journal-title":"Oncogene"},{"key":"R33-14-20241201","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo.","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R34-14-20241201","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/hupa.2001.22747","article-title":"Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas.","volume":"32","author":"Paradis","year":"2001","journal-title":"Hum Pathol"},{"key":"R35-14-20241201","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/0016-5085(95)90455-7","article-title":"Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study.","volume":"108","author":"Borzio","year":"1995","journal-title":"Gastroenterology"},{"key":"R36-14-20241201","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/hep.510230527","article-title":"Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.","volume":"23","author":"GanneCarrie","year":"1996","journal-title":"HEPATOLOGY"},{"key":"R37-14-20241201","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00000478-199703000-00007","article-title":"Largecell change of hepatocytes in cirrhosis may represent a reaction to prolonged cholestasis.","volume":"21","author":"Natarajan","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R38-14-20241201","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.21552","article-title":"Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis.","volume":"45","author":"Plentz","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R39-14-20241201","first-page":"536","article-title":"Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia.","volume":"7","author":"Cohen","year":"1994","journal-title":"Mod Pathol"},{"key":"R40-14-20241201","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF00195775","article-title":"Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma.","volume":"424","author":"Zhao","year":"1994","journal-title":"Virchows Archiv"},{"key":"R41-14-20241201","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/jcp.50.5.394","article-title":"Apoptosis in human hepatocellular carcinoma and in liver cell dysplasia is correlated with p53 protein immunoreactivity.","volume":"50","author":"Zhao","year":"1997","journal-title":"J Clin Pathol"},{"key":"R42-14-20241201","first-page":"703","article-title":"Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature.","volume":"21","author":"Hytiroglou","year":"1995","journal-title":"HEPATOLOGY"},{"key":"R43-14-20241201","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0168-8278(97)80321-2","article-title":"Prevalence of liver cell dysplasia and association with HCC in series of 100 cirrhotic liver explants.","volume":"27","author":"Le Bail","year":"1997","journal-title":"J Hepatol"},{"key":"R44-14-20241201","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0016-5085(93)90432-C","article-title":"Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B.","volume":"104","author":"Lefkowitch","year":"1993","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23072","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200909000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:28:46Z","timestamp":1733059726000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200909000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23072","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}